Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Pleural Diseases Market Valuation Change Between Now And 2029?

There has been significant growth in the size of the pleural diseases market in recent past. It’s projected to rise from $4.86 billion in 2024 to $5.21 billion in 2025, marking a compound annual growth rate (CAGR) of 7.3%. Factors influencing this growth during the historic period include an increase in cases of pleural effusion, heightened awareness of pleural diseases, a greater emphasis on early diagnosis, expanded healthcare facilities, and an increase in clinical trials related to pleural disease.

The market for pleural diseases is predicted to witness a robust expansion in the coming years, increasing to $6.88 billion in 2029 with a 7.2% compound annual growth rate (CAGR). Several factors contribute to this growth within the forecast period including an uptick in cases of pleural diseases, aging population increase, rise in occupational hazards, increased clinical trials, and a growing number of diagnostic centers. The period is also expected to see significant trends such as improvements in diagnostic procedures, progress in diagnostic tools, wider acceptance of minimally invasive procedures, advancements in drug development, and the embrace of telemedicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

What Growth-Enabling Forces Are Impacting The Pleural Diseases Market?

The growth of the pleural diseases market is projected to be fuelled by the rising incidents of infectious diseases. These diseases are triggered by harmful microorganisms like bacteria, viruses, fungi, or parasites. Various factors, such as changes in human behavior and global travel advancements, contribute to the growing cases of these diseases. Infectious diseases like bacterial pneumonia, tuberculosis, or viral infections can lead to pleural disease as they incite inflammation, infection or fluid build-up in the pleural cavity. For example, as per the National Library of Medicine – a US-based medical library for research and information – in January 2023, over 52 million deaths annually were due to infectious diseases, putting half of the world’s population at risk. Additionally, nearly 14 million children under five years die every year, with 70% of these deaths linked to preventable diseases through vaccination. Consequently, the escalating frequency of infectious diseases propels the growth of the pleural diseases market.

What Are The Main Segment Classifications In The Pleural Diseases Market?

The pleural diseasesmarket covered in this report is segmented –

1) By Disease Type: Pleurisy; Pleural Effusion; Pneumothelioma; Mesothelioma; Other Disease Types

2) By Treatment Modalities: Medications; Thoracentesis And Pleurodesis; Minimally Invasive Interventions; Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques; Molecular Diagnostics; Thoracoscopy; Pleuroscopy

4) By End User: Hospitals And Clinics; Diagnostic Centers; Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy; Chronic Pleurisy; Infectious Pleurisy; Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion; Exudative Pleural Effusion; Malignant Pleural Effusion; Parapneumonic Pleural Effusion; Hemothorax; Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma; Secondary Pneumothelioma (Metastatic); Localized Pneumothelioma; Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma; Peritoneal Mesothelioma; Pericardial Mesothelioma; Testicular Mesothelioma

5) Other Disease Types: Pulmonary Embolism; Fibrothorax; Pneumothorax; Lung Cancer; Tuberculosis-Related Pleural Disease; Sarcoidosis

How Are Market Trends Influencing Competition In The Pleural Diseases Market?

Leading companies in the pleural diseases market are developing ready-to-use injectable therapies to improve convenience, cut preparation time, and reduce dosing errors. Ready-to-use injectables come pre-formulated and pre-diluted, eliminating the need for reconstitution. For instance, in April 2024, Amneal Pharmaceuticals, a US pharmaceutical firm, launched PEMRYDI RTU, the first ready-to-use form of pemetrexed for injection. This product aids patients with pleural diseases by providing easy-to-administer therapy that minimizes preparation time and dosing mistakes, improving treatment for conditions like malignant pleural mesothelioma.

Which Firms Are Driving Innovation Within The Pleural Diseases Market?

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

What Are The Emerging Regional Trends Driving The Pleural Diseases Market?

North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

Browse Through More Reports Similar to the Global Pleural Diseases Market 2025, By The Business Research Company

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Rare Diseases Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Kidney Diseases Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model